StreetInsider.com News Articles

Form 6-K POMDOCTOR Ltd For: Oct 19

Mon, 19 Oct 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20261019/27201545.html

POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq

Mon, 19 Oct 2026 08:30:00 -0400

GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today announced that it has commenced to terminate its American Depositary Receipt program (the "ADR Program"), including the termination of the related deposit agreement, as amended, and list the Company's Class A ordinary shares directly on The Nasdaq Stock Market LLC ("Nasdaq").

POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq

Mon, 19 Oct 2026 08:30:00 -0400

Pomdoctor outlines strategy to shift toward AI-driven predictive care

Mon, 12 Oct 2026 08:02:39 -0400

Pomdoctor Limited (NASDAQ: POM), a digital healthcare company based in Guangzhou, China, has outlined a strategy to transition its operations toward a predictive healthcare model, according to a press release statement from the company.

The company said it plans to integrate AI, wearable technologies, remote patient monitoring capabilities and real-world healthcare data with its existing healthcare operations and physician resources into a coordinated healthcare management framework.

Pomdoctor described the broader healthcare industry as moving from a reactive model — in which patients seek care after symptoms appear — toward a more proactive approach that uses continuous monitoring and data analysis to identify

POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare

Mon, 12 Oct 2026 08:00:00 -0400

GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today highlighted its strategy to participate in the ongoing transformation of healthcare from a traditionally reactive model centered on treating illness after it occurs toward a more predictive and proactive approach to health management.

POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare

Mon, 12 Oct 2026 08:00:00 -0400

Form 6-K POMDOCTOR Ltd For: Oct 09

Fri, 09 Oct 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20261009/27171864.html

Pomdoctor faces Nasdaq delisting over minimum bid price failure

Fri, 09 Oct 2026 16:06:04 -0400

Pomdoctor Limited (NASDAQ: POM), a China-based digital healthcare company, announced it received a staff determination letter from Nasdaq's Listing Qualifications Department on October 6, 2026, notifying the company that its American depositary shares are subject to delisting from The Nasdaq Global Market.

Nasdaq informed the company that its ADS closing bid price remained below $1.00 per share for 30 consecutive business days, from August 24, 2026 through October 5, 2026, placing it in violation of Nasdaq Listing Rule 5450(a)(1), the minimum bid price requirement.

Under normal circumstances, a listed company would receive a 180-calendar-day period to regain compliance. However, Pomdoctor is ineligible

POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination

Fri, 09 Oct 2026 16:05:00 -0400

GUANGZHOU, China, Oct. 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that it received a staff determination letter (the "Letter") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on October 6, 2026.

POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination

Fri, 09 Oct 2026 16:05:00 -0400

Form 6-K POMDOCTOR Ltd For: Oct 02

Fri, 02 Oct 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20261002/27142129.html

Form 6-K POMDOCTOR Ltd For: Sep 30

Wed, 30 Sep 2026 08:38:00 -0400

si-local-file:///var/storage/secattach/20260930/27125900.html

POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

Wed, 30 Sep 2026 08:00:00 -0400

GUANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an update on the continued progress in the development and commercialization of its AI-enabled chronic disease management ecosystem, including further optimization of its proprietary AI chronic disease management system, expanded real-world data ("RWD") applications, and integrated in-hospital and out-of-hospital chronic disease management pilots.

POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

Wed, 30 Sep 2026 08:00:00 -0400

Form 6-K POMDOCTOR Ltd For: Jun 30

Tue, 29 Sep 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260929/27122344.html

Form 6-K POMDOCTOR Ltd For: Sep 24

Thu, 24 Sep 2026 08:17:00 -0400

si-local-file:///var/storage/secattach/20260924/27099217.html

POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model

Thu, 24 Sep 2026 08:00:00 -0400

GUANGZHOU, China, Sept. 24, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today highlighted its differentiated "hardware + AI + payment" infrastructure model. The Company believes this integrated approach distinguishes it from traditional internet healthcare platforms and positions Pomdoctor to evolve into a comprehensive digital healthcare technology infrastructure provider.

While conventional internet

POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model

Thu, 24 Sep 2026 08:00:00 -0400

While conventional internet

Form 6-K POMDOCTOR Ltd For: Sep 10

Thu, 10 Sep 2026 08:11:00 -0400

si-local-file:///var/storage/secattach/20260910/27045557.html

POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:00:00 -0400

Virtual company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET

GUANGZHOU, China, Sept. 10, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today announced that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September 14 through September 16, 2026, at the Lotte New York Palace Hotel in New York City.

A pre-recorded presentation from the Company as part of the conference will be available on demand

POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:00:00 -0400

Virtual company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET

A pre-recorded presentation from the Company as part of the conference will be available on demand

Form 6-K POMDOCTOR Ltd For: Aug 27

Thu, 27 Aug 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260827/26985160.html

Form 6-K POMDOCTOR Ltd For: Aug 27

Thu, 27 Aug 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260827/26985160.html

POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy

Thu, 27 Aug 2026 08:00:00 -0400

GUANGZHOU, China, Aug. 27, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today announced the formal initiation of its U.S. market entry preparations, marking a decisive advancement in its global growth strategy.

As part of the initiative, Pomdoctor has recently commenced recruitment for core U.S.-based leadership and operational roles, completed an initial assessment of the U.S. healthcare market, and begun structuring a dedicated local compliance and regulatory framework. Concurrently, the Company is advancing

POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy

Thu, 27 Aug 2026 08:00:00 -0400